AFFLUENT n (%) | DEPRIVED n (%) | Chi squared test result | ||||
---|---|---|---|---|---|---|
PATHOLOGICAL PROGNOSTIC FACTORS | ||||||
SIZE* |
WHOLE SAMPLE
n = 136 |
CONSENTED SAMPLE
n = 72 |
WHOLE SAMPLE
n = 194 |
CONSENTED SAMPLE
n = 91 | WHOLE SAMPLE | CONSENTED SAMPLE |
0 – 19 mm | 70 (51.5%) | 42 (58.3%) | 106 (54.6%) | 54 (59.3%) | X ^{2} = 0.53 | X ^{2} = 0.04 |
20 – 49 mm | 62 (45.6%) | 29 (40.3%) | 81 (41.8%) | 36 (39.6%) | DF = 2 | DF = 2 |
>50 mm | 4 (2.9%) | 1 (1.4%) | 7 (3.6%) | 1 (1.1%) | p = 0.76 | p = 0.98 |
GRADE* | n = 110 | n = 59 | n = 156 | n = 72 | ||
1 | 17 (15.5%) | 9 (15.3%) | 30 (19.2%) | 18 (25.0%) | X ^{2} = 0.66 | X ^{2} = 1.83 |
2 | 67 (60.9%) | 39 (66.1%) | 92 (59.0%) | 42 (58.3%) | DF = 2 | DF = 2 |
3 | 26 (23.6%) | 11 (18.6%) | 34 (21.8%) | 12 (16.7%) | p = 0.72 | p = 0.34 |
NODAL STATUS* | n = 128 | n = 72 | n = 196 | n = 93 | ||
Positive | 48 (37.5%) | 24 (33.3%) | 72 (36.7%) | 28 (30.1%) | X ^{2} = 0.01 | X ^{2} = 0.196 |
Negative | 80 (62.5%) | 48 (66.6%) | 124 (63.3%) | 65 (69.9%) |
DF = 1
p = 0.88 |
DF = 2
p = 0.736 |
CLINICAL STAGE AT PRESENTATION | ||||||
n = 156 | n = 260 | |||||
Early | 146 (93.6%) | 100% | 220 (84.6%) | 100% | X ^{2} = 7.42 | N/A |
Locally advanced or metastatic | 10 (6.4%) | 40 (15.4%) |
DF = 1
p = 0.006 |